Fusion Antibodies is delighted to be attending The 21st Annual Discovery on Target (DOT), in Sheraton, Boston, MA, on September 25-28, 2023. Discovery on Target (DOT) highlights advances in current and emerging novel targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules. Find out more here.

If you are planning to attend this event, stop by booth #219 in the exhibit hall. If you would like to set up a meeting to discuss our capabilities or to find out more about how we can advance your project to the next stage, please contact us here.

About Fusion Antibodies

Fusion Antibodies is an end-to-end antibody discovery partner offering a range of services in antibody generation, development, production, characterisation, and optimisation.

We have guided hundreds of projects through critical pre-clinical stages, repeatedly proving our expertise as we strive to bring about a positive change in the healthcare industry.